Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Journal article

Pollard S. et al, (2021), European Journal of Human Genetics

Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.

Journal article

Vellekoop H. et al, (2021), Pharmacoeconomics

Availability and Funding of Clinical Genomic Sequencing Globally

Journal article

Phillips KA. et al, (2021), BMJ Global Health

Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom

Journal article

BUCHANAN J. et al, (2021), Applied Health Economics and Health Policy

FINANCING AND REIMBURSEMENT FOR PERSONALISED MEDICINE - ARE WE THERE YET?

Presentation

Koleva-Kolarova R. et al, (2020), VALUE IN HEALTH, 23, S756 - S756

Delayed Antibiotic Prescription by General Practitioners in the UK: A Stated-Choice Study.

Journal article

Morrell L. et al, (2020), Antibiotics (Basel), 9

Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.

Journal article

Marshall DA. et al, (2020), Value Health, 23, 566 - 573

Implications of secondary findings for clinical contexts

Chapter

MORRISON M. et al, (2020), Secondary Findings in Genomic Research, 155 - 201

Load More